Nicolas Poirier

2.5k total citations
69 papers, 1.5k citations indexed

About

Nicolas Poirier is a scholar working on Immunology, Oncology and Transplantation. According to data from OpenAlex, Nicolas Poirier has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Immunology, 16 papers in Oncology and 12 papers in Transplantation. Recurrent topics in Nicolas Poirier's work include Immune Cell Function and Interaction (31 papers), T-cell and B-cell Immunology (26 papers) and Immunotherapy and Immune Responses (20 papers). Nicolas Poirier is often cited by papers focused on Immune Cell Function and Interaction (31 papers), T-cell and B-cell Immunology (26 papers) and Immunotherapy and Immune Responses (20 papers). Nicolas Poirier collaborates with scholars based in France, Netherlands and United States. Nicolas Poirier's co-authors include Bernard Vanhove, Gilles Blancho, Caroline Mary, Nahzli Dilek, Flora Coulon, Bernard Martinet, Jérémy Hervouet, Karine Renaudin, Claire Usal and David Minault and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nicolas Poirier

66 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Poirier France	23	1.1k	311	249	223	194	69	1.5k
Flora Coulon France	18	653 0.6×	209 0.7×	136 0.5×	152 0.7×	202 1.0×	28	1.0k
Angela Stabilini Italy	17	1.3k 1.2×	153 0.5×	390 1.6×	237 1.1×	272 1.4×	23	1.9k
Susan K. Anderson United States	18	349 0.3×	141 0.5×	236 0.9×	149 0.7×	445 2.3×	30	1.3k
P. Gjörstrup Sweden	10	293 0.3×	117 0.4×	147 0.6×	187 0.8×	179 0.9×	15	912
Richard F. Olsson Sweden	26	317 0.3×	103 0.3×	630 2.5×	274 1.2×	257 1.3×	55	1.8k
David Coe United Kingdom	18	681 0.6×	40 0.1×	77 0.3×	223 1.0×	247 1.3×	27	1.1k
A. Ythier France	18	565 0.5×	59 0.2×	92 0.4×	233 1.0×	308 1.6×	38	1.3k
Christopher Geehan United States	11	424 0.4×	69 0.2×	168 0.7×	251 1.1×	335 1.7×	12	924
Ingrid C. Rulifson United States	16	835 0.8×	48 0.2×	693 2.8×	160 0.7×	599 3.1×	22	1.8k

Countries citing papers authored by Nicolas Poirier

Since Specialization

Citations

This map shows the geographic impact of Nicolas Poirier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Poirier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Poirier more than expected).

Fields of papers citing papers by Nicolas Poirier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Poirier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Poirier. The network helps show where Nicolas Poirier may publish in the future.

Co-authorship network of co-authors of Nicolas Poirier

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Poirier. A scholar is included among the top collaborators of Nicolas Poirier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Poirier. Nicolas Poirier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pengam, Sabrina, et al.. (2025). DOP031 Anti-IL-7 receptor plus anti-IL12/23 combination induces complete histological normalization in chronic colitis. Journal of Crohn s and Colitis. 19(Supplement_1). i143–i143.

Mérieau, Emmanuel, Caroline Mary, Kévin Biteau, et al.. (2024). CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury. The Journal of Immunology. 212(7). 1178–1187. 4 indexed citations

Baccelli, Irène, Lennart Lenk, Beat Bornhäuser, et al.. (2023). Abstract 2957: CD127 is expressed by acute lymphoblastic leukemias and is efficiently targeted by the IL7R-antagonist OSE-127 through macrophage-mediated antibody dependent phagocytosis. Cancer Research. 83(7_Supplement). 2957–2957. 1 indexed citations

Champiat, Stéphane, Philippe A. Cassier, Nuria Kotecki, et al.. (2023). Abstract 2129: Predictive response biomarkers from Phase I clinical trial of a SIRPalpha inhibitor BI765063, stand-alone and in combination with ezabenlimab, a PD1 inhibitor, in patients with advanced solid tumors. Cancer Research. 83(7_Supplement). 2129–2129. 2 indexed citations

Baccelli, Irène, Caroline Mary, Géraldine Teppaz, et al.. (2023). 493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoralin vivoefficacies in humanized preclinical models. SHILAP Revista de lepidopterología. A555–A555. 1 indexed citations

Hémon, Patrice, Christelle Le Dantec, Loukas Chatzis, et al.. (2023). High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome. Journal of Autoimmunity. 149. 103147–103147. 2 indexed citations

Champiat, Stéphane, Philippe A. Cassier, Nuria Kotecki, et al.. (2021). Safety, pharmacokinetics, efficacy, and preliminary biomarker data of first-in-class BI 765063, a selective SIRPα inhibitor: Results of monotherapy dose escalation in phase 1 study in patients with advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 2623–2623. 24 indexed citations

Rivière, Élodie, Juliette Pascaud, Bineta Ly, et al.. (2020). Interleukin‐7/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjögren’s Syndrome. Arthritis & Rheumatology. 73(4). 631–640. 39 indexed citations

Doxiadis, Gaby G. M., Nanine de Groot, Ńel Otting, et al.. (2018). MHC class I diversity of olive baboons (Papio anubis) unravelled by next-generation sequencing. Immunogenetics. 70(7). 439–448. 10 indexed citations

10.

Laurent, Lætitia, Mélanie Néel, Caroline Mary, et al.. (2017). Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28. European Journal of Immunology. 47(8). 1368–1376. 15 indexed citations

11.

Vanhove, Bernard, Nicolas Poirier, Fádi Fakhouri, et al.. (2017). Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders. Antibodies. 6(4). 19–19. 10 indexed citations

12.

Groot, Nanine de, Annemiek J. M. de Vos‐Rouweler, Natasja G. de Groot, et al.. (2017). A quick and robust MHC typing method for free-ranging and captive primate species. Immunogenetics. 69(4). 231–240. 11 indexed citations

13.

Poirier, Nicolas, Gilles Blancho, Caroline Mary, et al.. (2016). First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28. The Journal of Immunology. 197(12). 4593–4602. 47 indexed citations

14.

Vierboom, Michel, Yolanda S. Kap, Caroline Mary, et al.. (2015). Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clinical & Experimental Immunology. 183(3). 405–418. 20 indexed citations

15.

Mary, Caroline, Flora Coulon, Nicolas Poirier, et al.. (2013). Antagonist properties of monoclonal antibodies targeting human CD28. mAbs. 5(1). 47–55. 18 indexed citations

16.

Poirier, Nicolas, Caroline Mary, Nahzli Dilek, et al.. (2012). Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody. American Journal of Transplantation. 12(10). 2630–2640. 56 indexed citations

17.

Mary, Caroline, Flora Coulon, Nicolas Poirier, et al.. (2012). Antagonist properties of monoclonal antibodies to human CD28: role of valency and heavy-chain constant domain. Journal of Translational Medicine. 10(S3). 1 indexed citations

18.

Poirier, Nicolas, Nahzli Dilek, Caroline Mary, & Bernard Vanhove. (2012). Preclinical Efficacy and Immunological Safety of FR104, An Antagonist Anti-CD28 Monovalent Fabʼantibody, in Humanized Mice Models. Transplantation. 94(10S). 136–136. 1 indexed citations

19.

Tillou, X., Nicolas Poirier, Stéphanie Le Bas‐Bernardet, et al.. (2010). Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons. Kidney International. 78(2). 152–159. 69 indexed citations

20.

Klassen, J, et al.. (1979). Autoimmune myocarditis: a clinical entity.. PubMed. 120(3). 317–21. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact